1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. South & Central America Transfection Reagents and Equipment Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. South & Central America Transfection Reagents and Equipment Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. South & Central America Transfection Reagents and Equipment Market Regional Analysis
6.2 South & Central America Transfection Reagents and Equipment Market Revenue 2020-2030 (US$ Million)
6.3 South & Central America Transfection Reagents and Equipment Market Forecast Analysis
7. South & Central America Transfection Reagents and Equipment Market Analysis – by Product
7.1 Reagents and Instruments
- 7.1.1 Overview
- 7.1.2 Reagents and Instruments: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. South & Central America Transfection Reagents and Equipment Market Analysis – by Method
8.1 Viral Methods
- 8.1.1 Overview
- 8.1.2 Viral Methods: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Non Viral Methods
- 8.2.1 Overview
- 8.2.2 Non Viral Methods: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Hybrid Methods
- 8.3.1 Overview
- 8.3.2 Hybrid Methods: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. South & Central America Transfection Reagents and Equipment Market Analysis – by End User
9.1 Academics & Research Institutes and Pharmaceutical & Biotechnology Companies
- 9.1.1 Overview
- 9.1.2 Academics & Research Institutes and Pharmaceutical & Biotechnology Companies : South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. South & Central America Transfection Reagents and Equipment Market – South and Central America Analysis
10.1 Overview
10.2 South and Central America
- 10.2.1 South & Central America Transfection Reagents and Equipment Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.2.1.1 South & Central America Transfection Reagents and Equipment Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 Brazil:
South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.1.1 Brazil: South & Central America Transfection Reagents and Equipment Market Breakdown, by Product
- 10.2.1.1.2 Brazil: South & Central America Transfection Reagents and Equipment Market Breakdown, by Method
- 10.2.1.1.3 Brazil: South & Central America Transfection Reagents and Equipment Market Breakdown, by End User
- 10.2.1.2 Argentina:
South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.2.1 Argentina: South & Central America Transfection Reagents and Equipment Market Breakdown, by Product
- 10.2.1.2.2 Argentina: South & Central America Transfection Reagents and Equipment Market Breakdown, by Method
- 10.2.1.2.3 Argentina: South & Central America Transfection Reagents and Equipment Market Breakdown, by End User
- 10.2.1.3 Rest of South and Central America :
South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.3.1 Rest of South and Central America : South & Central America Transfection Reagents and Equipment Market Breakdown, by Product
- 10.2.1.3.2 Rest of South and Central America : South & Central America Transfection Reagents and Equipment Market Breakdown, by Method
- 10.2.1.3.3 Rest of South and Central America : South & Central America Transfection Reagents and Equipment Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Thermo Fisher Scientific Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Promega Corp
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Bio-Rad Laboratories Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Mirus Bio LLC
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 QIAGEN NV
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Merck KGaA
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Lonza Group AG
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 MaxCyte Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations